Recurrent Clostridioides Difficile Infection
The Recurrent Clostridioides Difficile Infection pipeline: 2 tracked drugs, 1 approved for this indication.
Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Recurrent Clostridioides Difficile Infection, so this list is not complete.
1 approved / phase 41 preclinical / unstaged
Market size not yet sourced. How markets are sized ↗